Cancer services are beginning to get up and running across the country, but we’re still a long way from either restoring capacity or addressing the backlog of people waiting for tests and treatment.
A new breed of targeted cancer drug has been approved for NHS use in England. But drugs like larotrectinib also pose unique and complex challenges for the NHS, which have been exacerbated by the COVID-19 pandemic.
Cancer services have been severely disrupted across the UK, from screening to treatment and care.
In light of the COVID-19 pandemic and it’s impact on our fundraising, we’ve had to cut our research spend. Here’s everything you need to know.
Life expectancy has failed to increase for a decade across England for the first time in 100 years. And cuts to stop smoking services are part of the problem.
What do the latest recommendations from Sir Mike Richards mean for screening in England? We take a look.
With the Government redesigning the immigration system, we spoke to Dr Susanne Gatz about the importance of travelling across Europe for her work.
Waiting to hear if you have cancer, or if your cancer has come back, can be an extremely stressful time – especially if the results take weeks to come back.
Diagnosing cancer at its earliest and most treatable stages is vital to help more people survive their cancer. But it requires having enough NHS staff in place.